Sept 5 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO REPORTS PRELIMINARY DATA COLLECTED FROM >2,000 BRINAVESS® TREATMENT EPISODES IN EU POST-AUTHORIZATION SAFETY STUDY
* CORREVIO PHARMA CORP - 28 SERIOUS ADVERSE EVENTS WERE REPORTED FOR 26 PATIENTS AND NO DEATHS WERE REPORTED IN STUDY EVALUATING BRINAVESS